Fidelity Investments’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,791
| Closed | -$7.95K | – | 5681 |
|
|
2024
Q2 | $7.95K | Buy |
6,791
+4,265
| +169% | +$4.99K | ﹤0.01% | 4407 |
|
|
2024
Q1 | $3.18K | Buy |
2,526
+2,456
| +3,509% | +$3.1K | ﹤0.01% | 4607 |
|
|
2023
Q4 | $125 | Sell |
70
-279
| -80% | -$498 | ﹤0.01% | 4921 |
|
|
2023
Q3 | $580 | Buy |
349
+244
| +232% | +$406 | ﹤0.01% | 4700 |
|
|
2023
Q2 | $210 | Buy |
+105
| New | +$210 | ﹤0.01% | 4899 |
|
|
2020
Q3 | – | Sell |
-2
| Closed | – | – | 3921 |
|
|
2020
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 4037 |
|
|
2020
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 4116 |
|
|
2019
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4158 |
|
|
2014
Q3 | – | Sell |
-106,679
| Closed | -$3.89M | – | 2813 |
|
|
2014
Q2 | $3.89M | Sell |
106,679
-8,000
| -7% | -$292K | ﹤0.01% | 2292 |
|
|
2014
Q1 | $5.25M | Hold |
114,679
| – | – | ﹤0.01% | 2195 |
|
|
2013
Q4 | $4.46M | Hold |
114,679
| – | – | ﹤0.01% | 2202 |
|
|
2013
Q3 | $5.2M | Sell |
114,679
-5,230
| -4% | -$237K | ﹤0.01% | 2143 |
|
|
2013
Q2 | $5.89M | Buy |
+119,909
| New | +$5.89M | ﹤0.01% | 2091 |
|